Healthy Minds

UN Relations have been developed to begin Phase 1 clinical studies on a variety of hallucinogenic compounds in a controlled setting.

Schedule 1 drug clearance protocol has been approved to study the following active chemical compounds.  

image-1.png

Psilocybin 

An active compound found in "Magic" Mushrooms, this chemical has been shown to increase neural plasticity. 

Peyote-1.png

Mescaline

Commonly found in the Peyote Cactus to treat addiction with a success rate of over 95% in controlled clinical settings. 

LSD25.png

Lysergic Acid 

LSD was used for the first time in 2017 in a clinical study within the UK with a 98% success rate treating depression. 

Delosperma_tradescantioides_leafs_IMGP0042.png

Tryptamine 

DMT found in Ayahuasca is known as the Spirit molecule. Almost all user's report an improved quality of life after using the compound. 

Mental Disorder's affect over 3 billion people. Hallucinogenic compounds in a controlled clinical setting are a viable neuropsychological treatment. 

Spirit Mental .png